The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Inhibition of Fibrocyte Differentiation by Serum Amyloid P
Open accessAbstract
Wound healing and the dysregulated events leading to fibrosis both involve the proliferation and differentiation of fibroblasts and the deposition of extracellular matrix. Whether these fibroblasts are locally derived or from a circulating precursor population is unclear. Fibrocytes are a distinct population of fibroblast-like cells derived from peripheral blood monocytes that enter sites of tissue injury to promote angiogenesis and wound healing. We have found that CD14+ peripheral blood monocytes cultured in the absence of serum or plasma differentiate into fibrocytes within 72 h. We purified the factor in serum and plasma that prevents the rapid appearance of fibrocytes, and identified it as serum amyloid P (SAP). Purified SAP inhibits fibrocyte differentiation at levels similar to those found in plasma, while depleting SAP reduces the ability of plasma to inhibit fibrocyte differentiation. Compared with sera from healthy individuals and patients with rheumatoid arthritis, sera from patients with scleroderma and mixed connective tissue disease, two systemic fibrotic diseases, were less able to inhibit fibrocyte differentiation in vitro and had correspondingly lower serum levels of SAP. These results suggest that low levels of SAP may thus augment pathological processes leading to fibrosis. These data also suggest mechanisms to inhibit fibrosis in chronic inflammatory conditions, or conversely to promote wound healing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Steel, D. M., & Whitehead, A. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90138-4 · Cited by 1,025
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
Abe, R., Donnelly, S. C., Peng, T., Bucala, R., & Metz, C. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7556 · Cited by 967 · cited 8×
“Fibrocytes also differentiate in vitro after 1–2 wk in culture in the presence of serum (7, 11).”
BackgroundInfluentialHuman C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D., & Salmon, M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01863-4 · Cited by 796
Self-citationCLARK, R. A. F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03522.x · Cited by 507
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
Bickerstaff, M. C. M., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J. G., Walport, M. J., et al. (1999) · Nature Medicine · doi:10.1038/9544 · Cited by 489
The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Regulated Production of Type I Collagen and Inflammatory Cytokines by Peripheral Blood Fibrocytes
Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M., & Bucala, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.419 · Cited by 375
Chesney, J., Bacher, M., Bender, A., & Bucala, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6307 · Cited by 343
Buckley, C. D., Amft, N., Bradfield, P. F., Pilling, D., Ross, E., Arenzana-Seisdedos, F., Amara, A., Curnow, S. J., Lord, J. M., Scheel-Toellner, D., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3423 · Cited by 330
Self-citationStructure and function of the pentraxins
Gewurz, H., Zhang, X.-H., & Lint, T. F. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80029-8 · Cited by 328
Hartlapp, I., Abe, R., Saeed, R. W., Peng, T., Voelter, W., Bucala, R., & Metz, C. N. (2001) · The FASEB Journal · doi:10.1096/fj.01-0049com · Cited by 265
Amyloid P-component is a constituent of normal human glomerular basement membrane.
Dyck, R. F., Lockwood, C. M., Kershaw, M., McHugh, N., Duance, V. C., Baltz, M. L., & Pepys, M. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.5.1162 · Cited by 216
Cellular environments and apoptosis: tissue microenvironments control activated T-cell death
Akbar, A. N., & Salmon, M. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01003-7 · Cited by 214
Self-citationSalmon, M., Pilling, D., Borthwick, N. J., Viner, N., Janossy, G., Bacon, P. A., & Akbar, A. N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240417 · Cited by 196
Self-citationInterferon‐β mediates stromal cell rescue of T cells from apoptosis
Pilling, D., Akbar, A. N., Girdlestone, J., Orteu, C. H., Borthwick, N., Amft, N., Scheel‐Toellner, D., Buckley, C. D., & Salmon, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<1041::aid-immu1041>3.0.co;2-# · Cited by 195
Self-citationAmyloid P component is located on elastic fibre microfibrils in normal human tissue
Breathnach, S. M., Melrose, S. M., Bhogal, B., de Beer, F. C., Dyck, R. F., Tennentt, G., Black, M. M., & Pepys, M. B. (1981) · Nature · doi:10.1038/293652a0 · Cited by 192
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.
Pepys, M. B., Dash, A. C., Markham, R., Thomas, H. C., Williams, B. D., & Petrie, A. (1978) · PubMed Central · Cited by 188
Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin
Dahlbäck, B. (1983) · Biochemical Journal · doi:10.1042/bj2090837 · Cited by 182
Amyloid P component. A critical review
Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, I. M., & Hohenester, E. (1997) · Amyloid · doi:10.3109/13506129709003838 · Cited by 181
Woo, P., Korenberg, J. R., & Whitehead, A. S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38881-6 · Cited by 179
C-reactive protein binds to Fc γ RI in transfected COS cells
Marnell, L. L., Mold, C., Volzer, M. A., Burlingame, R. W., & Du Clos, T. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2185 · Cited by 164
Serum Amyloid P Component Binds to Fcγ Receptors and Opsonizes Particles for Phagocytosis
Bharadwaj, D., Mold, C., Markham, E., & Du Clos, T. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6735 · Cited by 158
BIOLOGY OF SERUM AMYLOID P COMPONENT*
Pepys, M. B., Baltz, M. L., de Beer, F. C., Dyck, R. F., Holford, S., BREATHNACH, S. M., Black, M. M., Tribe, C. R., Evans, D. J., & Feinstein, A. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22144.x · Cited by 142
A cell-counting factor regulating structure size in DictyosteliumPreprint
Brock, D. A., & Gomer, R. H. (1999) · Genes & Development · doi:10.1101/gad.13.15.1960 · Cited by 141
Self-citationMajno, G. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65648-9 · Cited by 138
Structural Requirements for the Complement Regulatory Activities of C4BP
Blom, A. M., Kask, L., & Dahlbäck, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102445200 · Cited by 137
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein.
Clos, T. W. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2553 · Cited by 124
Isolation of human C-reactive protein and serum amyloid P component.
de Beer, F. D., & Pepys, M. (1982) · JIM - Journal of Immunological Methods · doi:10.1016/0022-1759(82)90300-3 · Cited by 119
Pathology of Rheumatic Diseases
Fassbender, H. G. (1975) · Springer eBooks · doi:10.1007/978-3-662-09221-7 · Cited by 118
Schwalbe, R. A., Dahlbäck, B., & Nelsestuen, G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45804-8 · Cited by 97
Serum amyloid P component in chronic renal failure and dialysis.
Nelson, S. R., Tennent, G., Sethi, D., Gower, P., Ballardie, F. W., Amatayakul-Chantler, S., & Pepys, M. (1991) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/0009-8981(91)90090-y · Cited by 91
Regulation of phagocytic leukocyte activities by C-reactive protein
Mortensen, R. F., & Zhong, W. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.495 · Cited by 87
Peripheral blood fibrocytes: Mesenchymal precursor cells and the pathogenesis of fibrosis
Chesney, J. A., & Bucala, R. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0027-5 · Cited by 85
The genetics of systemic sclerosis
Johnson, R. W., Tew, M. B., & Arnett, F. C. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0004-2 · Cited by 71
Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum
Hutchinson, W. L., Hohenester, E., & Pepys, M. B. (2000) · Molecular Medicine · doi:10.1007/bf03401789 · Cited by 66 · cited 1×
“Serum and purified proteins were diluted to 1/1000 in TBS-4% BSA, to prevent SAP from aggregating (15), and incubated for 60 min at 37C.”
MethodGomer, R. H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048058 · Cited by 64
Self-citationHusby, G. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90001-t · Cited by 54
AMYLOID P-COMPONENT IN HUMAN GLOMERULAR BASEMENT MEMBRANE
Dyck, R. F., Lockwood, C. M., Turner, D., Evans, D. J., Rees, A. J., & Pepys, M. B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90281-0 · Cited by 52
Hawkins, P. N., Rossor, M., Gallimore, J., Miller, B., Moore, E., & Pepys, M. (1994) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1994.1760 · Cited by 52
CD4+CD45RA+T cells from adults respond to recall antigens after CD28 ligation
Pilling, D., Akbar, A. N., BACON, P. A., & Salmon, M. (1996) · International Immunology · doi:10.1093/intimm/8.11.1737 · Cited by 48
Self-citationCharacterization of Serum Amyloid P Component From Human Aortic Atherosclerotic Lesions
Li, X. A., Hatanaka, K., Ishibashi‐Ueda, H., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.252 · Cited by 45
Characterization of the Binding of Serum Amyloid P to Laminin
Zahedi, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/s0021-9258(19)78482-8 · Cited by 44
Immunohistochemical Studies of Amyloid P Component Distribution in Normal Human Skin
Breathnach, S. M., Melrose, S. M., Bhogal, B. S., de Beer, F. C., Black, M. M., & Pepys, M. B. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12531608 · Cited by 42
Characterization of the Binding of Serum Amyloid P to Type IV Collagen
Zahedi, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14897 · Cited by 36
The kinetics of interaction between lymphocytes and magnetic polymer particles
Pilling, D., Kitas, G. D., Salmon, M., et al. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90269-x · Cited by 25
Self-citationAf, S., & Pm, J. (1982) · PubMed · Cited by 11
Cited by
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Humphreys, B. D., Lin, S.-L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., & Duffield, J. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090517 · Cited by 1,442
Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295
Stromal myofibroblasts are drivers of invasive cancer growth
De Wever, O., Demetter, P., Mareel, M., & Bracke, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23925 · Cited by 722
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Metadata
- Authors
- Pilling, D., Buckley, C. D., Salmon, M., & Gomer, R. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11
- Volume
- 171
- Issue
- 10
- Pages
- 5537-5546
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1633651668
- Cited by
- 308
- References
- 52
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.